Hyperaldosteronism: Difference between revisions
m dx page format cleanup |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Conn's Syndrome| CurrentStatus = | | OldDxArticle =Conn's Syndrome| CurrentStatus = reconciled | ||
| InitialEditorAssigned = Gail Hall | | InitialEditorAssigned = Gail Hall | ||
}} | }} | ||
| Line 20: | Line 20: | ||
== Alternate ICD10s to consider coding instead or in addition == | == Alternate ICD10s to consider coding instead or in addition == | ||
*[[Electrolyte disorder, NOS]] | |||
*[[Metabolic disorder, NOS]] | |||
*[[Adrenal gland, metastatic malignancy to it (also code primary site)]] | |||
*[[Adrenal gland, benign neoplasm]] | |||
*[[Adrenal gland, primary malignancy]] | |||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||